GSK and Vir Biotechnology announce EMA review of dual-action monoclonal antibody VIR-7831 for the early treatment of COVID-19 Read more
FDA Grants Accelerated Approval to Trodelvy for the Treatment of Metastatic Urothelial Cancer Read more
AstraZeneca to supply the US with up to half a million additional doses of the potential COVID-19 antibody treatment AZD7442 Read more
Novartis ligelizumab (QGE031) receives FDA Breakthrough Therapy designation for patients with chronic spontaneous urticaria (CSU) Read more
Rocket Pharmaceuticals Announces Buildout of R&D and Manufacturing Facility to Support Development of Innovative Gene Therapy Pipeline Read more
FDA approves GSK’s BENLYSTA as the first medicine for adult patients with active lupus nephritis in the US Read more